Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
science, Volume 356, Issue 6341, 2017, Pages 938-945.
Antiretroviral-based strategies for HIV prevention have shown inconsistent results in women. We investigated whether vaginal microbiota modulated tenofovir gel microbicide efficacy in the CAPRISA (Centre for the AIDS Program of Research in South Africa) 004 trial. Two major vaginal bacterial community types—one dominated by Lactobacillus...More
Full Text (Upload PDF)